RFC180G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies-Reference-Cited by-同舟云学术

RFC180G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies

Published:2014-04-28 Issue:5 Volume:66 Page:1111-1120
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Kung Tabitha N.¹,Dennis Jessica²,Ma YiQing²,Xie Gang³,Bykerk Vivian⁴,Pope Janet⁵,Thorne Carter⁶,Keystone Edward¹,Siminovitch Katherine A.⁷,Gagnon France²

Affiliation:

1. Mount Sinai Hospital and University of Toronto; Toronto, Ontario Canada

2. University of Toronto; Toronto, Ontario Canada

3. Mount Sinai Hospital, Samuel Lunenfeld-Tanenbaum Research Institute, and Toronto General Research Institute; Toronto, Ontario Canada

4. Hospital for Special Surgery; New York New York

5. St. Joseph's Hospital and University of Western Ontario; London, Ontario Canada

6. University of Toronto and Southlake Regional Health Centre; Newmarket, Ontario Canada

7. Mount Sinai Hospital, Samuel Lunenfeld-Tanenbaum Research Institute, Toronto General Research Institute, and University of Toronto; Toronto, Ontario Canada

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference40 articles.

1. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs;Bykerk;J Rheumatol,2012

2. Long-term impact of delay in assessment of patients with early arthritis;Linden;Arthritis Rheum,2010

3. Toward a better understanding of methotrexate;Kremer;Arthritis Rheum,2004

4. Folate supplementation during methotrexate therapy for rheumatoid arthritis;Morgan;Clin Exp Rheumatol,2010

5. Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising;Gervasini;Curr Drug Metab,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between the efficacy and adverse effects of methotrexate and gene polymorphism;Egyptian Journal of Medical Human Genetics;2024-08-04

2. Pharmacogenetics of therapies in rheumatoid arthritis: An update;Best Practice & Research Clinical Rheumatology;2024-07

3. Towards Personalized Medicine in Rheumatoid Arthritis;Open Access Rheumatology: Research and Reviews;2024-05

4. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry;British Journal of Clinical Pharmacology;2024-02-18

5. Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis;Rheumatology;2023-06-16